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ChemometricsAbstract Alzheimer’s disease (AD) is one of the most common age-associated pathologies, which
inevitably leads to dementia and death. The aggregation of b-amyloid (Ab) peptides on plaques in
brain tissue is strongly associated with AD. The possible link between aluminum and AD still
remains controversial. In this work, the aggregation of Ab40 induced by Al(III) was investigated
with the use of the ﬂuorescence quenching method, UV–visible and circular dichroism spectro-
scopies as well as the atomic force microscopy technique. The results demonstrated that Al(III)
induced the transformation of the initial random coil structure to the b-sheet conﬁguration in
the Ab40 peptides. These structural changes facilitated the aggregation of Ab40. Also, the binding
constant was calculated with the use of the multivariate curve resolution-alternating least squares
(MCR-ALS) chemometrics method.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer’s disease (AD) is the most common neurodegenera-
tive disease, marked by clinical symptoms such as a decline incognitive skills, behavioral changes, irreversible memory loss,
and language impairment (Mattson, 2004). This illness is esti-
mated to affect approximately 2% of the population in indus-
trialized countries (Rauk, 2009). The pathological markers of
AD are the presence of extracellular amyloid plaques and
intracellular neuroﬁbrils because they can form tangles
(NFTs) (Chiti and Dobson, 2006). The major risk factor
known for AD is age; about 95% of the AD cases have no
clear pattern of inheriting the disease, and it appears that inter-
actions of both the genetic and environmental factors con-
tribute to the etiology of AD (Migliore and Coppede, 2009).
The exact mechanism leading to AD is still not established,
and there is no preventative protocol and no effective therapies
for AD. Thus, research in all aspects of AD is important
because, in general, the aims are to obtain a more completef Chem-
2 Q. Zhang et al.understanding of the AD, which eventually would lead to its
cure or at least a rational treatment.
Extracellular amyloid plaques are commonly referred to
as the senile plaques (SP); they are mainly made up of
b-amyloid (Ab) peptides, which exist in ﬁbrilar form
(Lovell et al., 1998). Such peptides are made from the amyloid
precursor protein (APP) by b- and c-secretase enzymes; also,
these peptides usually contain either 40 or 42 amino acids
(Ab40 and Ab42), respectively. Ab40 is the major product
of the APP processing, while Ab42 is the predominant
component of the senile plaques (Chiti and Dobson, 2006).
Thus, Ab neurotoxicity could result from an amyloid ﬁbrilar
aggregatie, and it has been suggested that the Ab-soluble
(Abs) oligomers are the principal neurotoxic agents, which,
even at very low concentrations, are capable of inducing
marked changes in neuronal long-term potentiation (LTP)
as well as in cognitive impairment (Lesne et al., 2005). Ab
peptides undergo spontaneous self-aggregation. However,
the origin of this phenomenon is still unclear. Thus, aggrega-
tion and the formation of oligomers of the Ab molecules are
ongoing topics of interest contributing to the etiology and
pathogenesis of AD.
Postmortem brain biopsies of AD patients have shown that
the aggregated Abs contain high concentrations of the metals,
Fe, Cu and Zn (Miller et al., 2006), and in general, the accumu-
lating evidence strongly indicates that metal ions are physio-
logical and pathological hallmarks of AD (Duce and Bush,
2010; Drew and Barnham, 2010; Molina et al., 2007).
Research has suggested that some metal ions play a distinct
role in the aggregation of Ab (Bush, 2003; Ricchelli et al.,
2006). These metal ions behave differently from those that
form the slowly self-assembled aggregates; rather, they acceler-
ate the dynamic aggregation of Ab. Consequently, the acceler-
ation of the dynamic aggregation process is likely to increase
the neurotoxic effects on the neuron cells. Aluminum (Al) is
the most widely distributed metal in the environment and is
extensively used in daily life (Kumar and Gill, 2009). It is
one of the metals that has a demonstrated human toxicity,
and is highly neurotoxic. In this context, Al was suspected to
be implicated in the progression of AD, when it was found
to induce the formation of neuro-ﬁbrilar tangles in the cere-
brum of rabbits (Klatzo et al., 1965; Terry and Pena, 1965).
However, over the years the role of Al in the etiology and
pathogenesis of AD has been controversial. While Al(III) is
known to aggregate in high concentrations in the AD amyloid
deposits, studies concerned with the linkage between Al and
AD have not reached consensus (Munoz, 1998; Zatta, 1993;
Zatta et al., 2003). Consequently, the question of the link
between Al (III) and AD remains of considerable interest
(Walton, 2006).
The aims of this work were:
1. to investigate the effect of Al(III) in aqueous solution on
the conformation and aggregation of Ab, and to relate
the ﬁndings to any effects on the AD;
2. to apply a chemometrics method of data analysis, namely
multivariate curve resolution-alternating least squares
(MCR-ALS) (Tauler, 1995), so as to explore whether this
approach can extract qualitative and/or quantitative infor-
mation, which otherwise is inaccessible to conventional
methods.Please cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.0192. Experimental section
2.1. Materials
Ab40 peptides (>95% pure) were purchased from GL
Biochem Ltd. (Shanghai). The lyophilized peptides (2.2 mg)
were dissolved in dimethylsulfoxide (DMSO, 5.0 mL) and son-
icated in a water bath for 5 min to solubilize any existing
aggregates. This solution was diluted with water (5.0 mL)
and ﬁltered through a 0.45 lm ﬁlter. The concentration of
Ab40 was immediately determined by absorption spectroscopy
(e = 1410 cm1 M1) (Edelhoch, 1967). It was labeled a stock
solution, which was kept in a refrigerator for further use.
Thioﬂavin T (ThT) was purchased from Sigma (USA) and
its stock solution was prepared by dissolving 63.8 mg of its
crystals in 10 mL 0.01 mol L1 Tris–HCl buffer (pH 7.4).
The aluminum solution (6.0 · 101 mol L1) was prepared
directly from aluminum chloride (Shanghai Reagent Factory,
Shanghai). Tris–HCl buffer (pH 7.4) was prepared by mixing
50 mL 0.1 M 2-Amino-2-hydroxymethyl-propane-1,3-diol
with 42 mL 0.1 M HCl, and diluted to 100 mL with water.
All other reagents were of analytical grade and used without
further puriﬁcation. All solutions used in the experiments were
adjusted with the Tris–HCl buffer (0.05 mol L1, pH 7.4) to
0.01 mol L1. Doubly distilled water was used throughout.
Four sample solutions, each diluted to 250 lL for experi-
ments (Section 2.3.3 and 2.3.4), were prepared: (1) fresh
Ab40 solution (prepared by 120 lL 50 lM Ab40 solution),
(2) Ab40 aggregates (prepared by 120 lL 50 lM Ab40 solu-
tion), and (3) and (4) Ab40 solution (prepared by 120 lL
50 lM Ab40 solution) + Al(III) solution (0.56 mM and
1.12 mM, respectively). Here the Al(III) was added to facilitate
the formation of Ab aggregates. A suitable amount of
Tris–HCl buffer was added to adjust the concentration of
Tris–HCl to 0.01 mol L1. Samples 2, 3 and 4 were immersed
in a water bath at 37 C for 3 days before analysis. These
samples were submitted to the following analyses: thioﬂavin
T ﬂuorescence, turbidity, circular dichroism and atomic force
microscopy.
2.2. Apparatus
UV–vis absorption spectra were recorded with an Agilent 8453
spectrophotometer (Agilent Technologies, Santa Clara, CA,
USA) using a 1.0 cm quartz cuvette. The ﬂuorescence spectra
were collected with an LS-55 luminescence spectrometer
(Perkin–Elmer Instruments, Waltham, MA, USA) equipped
with a thermostatic bath (Model ZC-10, Tianheng
Instruments Factory, Ningbo, China) and a 1.0 cm quartz cuv-
ette. Circular dichroism (CD) spectra were measured on a
MOS-450/AF-CD spectrometer (Bio-Logic Co., Marseille,
France) under constant nitrogen ﬂush with the use of a
1.0 cm quartz cuvette. The spectra were collected from samples
at pH 7.4 Tris–HCl buffer at room temperature (25 C); all
spectra were adjusted for any spectral contributions from the
buffer. The atomic force microscopy (AFM) images were
obtained with the use of an Agilent 5500 AFM (Agilent
Technologies, Santa Clara, CA, USA) in the tapping mode.
All the measurements were carried out at 25.0 ± 0.5 C unless
otherwise stated.eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
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2.3.1. Fluorescence quenching experiment
For this experiment, the ﬂuorescence associated with Ab40 was
quenched by Al(III), and this effect was measured on the addition
of Al(III) to the Ab solution (3.56 · 1.06 mol L1). The Al(III)
solution associated with this step were 0.0–7.5 · 106 mol L1
added at intervals of 5.0 · 107 mol L1. The reaction condi-
tions for each sample were as follows: the reaction medium
was 0.01 mol L1 Tris–HCl buffer and each solution was
allowed to stand for 5 min prior to scanning. The spectroscopic
scanning range was 260–500 nm (step of 2 nm, total 121 points)
with an excitation wavelength of 260 nm. Thus total 16 spectra
with 121 wavelengths were obtained.
2.3.2. Thioﬂavin T ﬂuorescence measurements
An aliquot of a sample (100 lL) was added to a cuvette (1 cm),
which contained ThT (1900 lL, 20 lM). This solution was
allowed to stand for 5 min, and then a ﬂuorescence spectrum
was recorded at an excitation wavelength of 440 nm in the
range of 420–620 nm.
2.3.3. UV–vis absorption experiments
A fresh 4.98 · 105 mol L1 Ab40 solution was prepared, and
a 1.88 · 105 mol L1 Al(III) solution was added to it sequen-
tially from 0.0 at intervals of 3.13 · 106 mol L1. After each
addition and thorough mixing, an absorption spectrum was
recorded in the range of 200–900 nm.
The absorption spectra of the freshly prepared Ab40, Ab40
aggregates, and Al(III) induced Ab40 aggregate solutions (see
Section 2.1), were collected immediately; the absorbance at
405 nm was recorded and considered to represent the turbidity
of the samples (Storr et al., 2007).
2.3.4. Circular dichroism spectra measurements
Sample solutions containing fresh Ab40, Ab40 oligomer, and
Al(III) induced Ab40 oligomer were scanned separately by
the use of a MOS-450/AF-CD spectrometer in a 1.0 cm quartz
cuvette over a wavelength range of 190–280 nm with a
scanning speed of 1 nm s1.
2.3.5. Atomic force microscope study
Samples for the AFM images were prepared by depositing
10 lL of a sample solution of fresh Ab40, Ab40 oligomer, or
Al(III) induced Ab40 oligomer, on freshly cleaved mica plates
(1.2 cm · 1.2 cm), which were dried overnight.
2.4. Chemometrics methods
Multivariate curve resolution–alternating least squares (MCR-
ALS) is a well-known multivariate self-modeling curve resolu-
tion method of data analysis, (Tauler, 1995). It facilitates a
bilinear decomposition of the experimental data matrix
according to the following algebraic model:
D ¼ C ST þ E ð1Þ
where D is the experimental data matrix with dimensions, M
(spectral objects)·N (wavelengths); C (M · F) is the concentra-
tion proﬁle matrix of F analytes in the samples; ST (F · N) is
the transposed matrix consisting of, for example, the emissionPlease cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.019spectra. The F rows of this matrix contain the pure spectra
associated with the F species in the samples; E (M · N) is the
residuals matrix. The number of F values is estimated by rank
analysis, with the use of singular value decomposition (SVD),
principal component analysis (PCA), or other related tech-
niques based on factor analysis, such as the evolving factor
analysis (EFA) method (Gampp et al., 1986). The MCR-
ALS procedure calculates the C and S matrices in turn by
the least squares method, and the iterative process is repeated
until convergence. When the number of species, F, and the ini-
tial estimates, which are required to initiate the iterative ALS
procedure (Vives et al., 2000), have been extracted, the
concentration proﬁles and the pure spectra of all the contributing
species can be established by the MCR-ALS method.3. Results and discussion
3.1. Investigation of the ﬂuorescence quenching
When excited by 260 nm radiation, the Ab40 peptides natu-
rally ﬂuoresce at 336 nm; this has been attributed to the
absorption of the impinging radiation by the tyrosine residues
(Rozga et al., 2010). The interaction between Al(III) and Ab40
was investigated by monitoring the quenching of the tyrosine
ﬂuorescence (Fig. 1A, Section 2.3.1). As expected, the addi-
tion of Al(III) resulted in a decrease of this ﬂuorescence, and
an isoactinic point formed at 400 nm; this indicated that a
chemical equilibrium existed in the system. Also, with the addi-
tion of Al(III), the ﬂuorescence peak broadened with a slight
blue shift; this suggested that on interacting with Al(III), the
microenvironment around the tyrosine residues of Ab40 was
affected. To investigate the spectra further, they were con-
verted to ﬁrst derivatives; often this type of data transforma-
tion facilitates the separation of any overlapping peaks.
The ﬁrst derivative proﬁles of the ﬂuorescence spectra chan-
ged signiﬁcantly on addition of the Al(III) (Fig. 1B). The pos-
itive proﬁles of the spectra indicated that initially there
appeared to be only one band present (spectrum 1); this, how-
ever, began to split into two major bands, which decreased
progressively in intensity. However, the intensity of this peak
at the lower wavelength (288 nm) stabilized after about the
tenth addition of Al(III), while the peak at about 315 nm
became apparent after about the fourth addition of the
Al(III). On further additions, this peak collapsed rapidly but
it still could be discerned in the last few spectral proﬁles.
Interestingly, from the 14 to 16th additions of Al(III), the
intensity of this peak, although low, stabilized. In addition,
when the ﬁrst-derivative of each of peak was overlaid then
the values of the spectral proﬁles were close to zero in the nar-
row wavelength range of 336–325 nm (see arrow, Fig. 1B). In
the negative parts of the spectral proﬁles, there were no easily
discernible proﬁle changes but a non-zero crossing point was
observed at about 338 nm, this means that the ﬂuorescence
spectral peaks were blue shifted, and the values of the tangent
slope of each spectrum were almost equal at this wavelength.
Overall, these observations indicated that the ﬂuorescence
emission spectra contained detailed information about the
interaction of Al(III) and Ab40, but in order to extract it,
the spectral proﬁles had to be processed by a method such as
MCR-ALS. This method is designed to extract quantitative
and qualitative information from spectral data.eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
Figure 1 (A) Fluorescence emission spectra of Ab40 (3.56 · 106 mol L1) after the addition of Al(III) (0–7.5 · 106 mol L1 at
intervals of 5.0 · 107 mol L1). (B) Derivative ﬂuorescence emission spectra. (C) Concentration proﬁles of the Ab40, Al(III) and Al(III)–
Ab40 analytes extracted from the ﬂuorescence data matrix by MCR-ALS. (D) Spectral proﬁles of the Ab40 and Al(III)–Ab40 analytes
extracted from the ﬂuorescence data matrix (dashed line: extracted).
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objects) · 121 (wavelengths), was ﬁrst submitted to EFA so as
to extract the signiﬁcant factors and three were obtained in this
case. This is consistent with the presence of Al(III), Ab40 and
the Al(III)–Ab40 complex; relative concentration proﬁles of
each chemical component involved in the interaction were then
obtained by the MCR-ALS method. Such information
together with the known initial concentration and the applica-
tion of the mass balance principal, produced the real quantita-
tive concentration proﬁle of each reaction component, by
using constraints, such as non-negativity and unimodality
(Fig. 1C). The initial drop in concentrations of the Al(III)
and Ab40 qualitatively supported the formation of an
Al(III)–Ab40 complex, and its change in concentration, quan-
titatively supported the buildup of this complex until it reached
a kinetic equilibrium position when [Al(III)]: [Ab40]  1; the
binding constant, Ka, was estimated as follows:
Ka ¼ ½AlðIIIÞ–Ab40=½AlðIIIÞ½Ab40 ð2Þ
where [Al(III)–Ab40], [Al(III)] and [Ab40] are the estimated
concentrations for the complex, free Al(III) and free Ab40,
respectively at each point of the concentration proﬁles. The
[Al(III)]: [Ab40] for the complex was about 1 (Fig. 1C), andPlease cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.019the value of Ka was calculated to be 2.63 · 105 mol L1 accord-
ing to Eq. (2). This indicated that there was a strong interac-
tion force between the Al(III) and Ab40. These observations
suggested that Al(III) could accelerate the kinetic aggregation
of Ab40. The value of Ka is qualitatively similar to values
reported in the literature, in which other techniques were
applied (Asandei et al., 2014). It should be kept in mind that
although previously reported metal afﬁnities of the various
Ab peptides seemed to vary appreciably, this can be accounted
for by taking into considerations the different experimental
conditions used in different studies, e.g., different models
reported the use of different buffers to inﬂuence the binding
of metals, and the initial aggregation states of the peptide
(Warmlander et al., 2013).
From the ﬁnally resolved pure spectra (Fig. 1D), qualita-
tive information about the nature of the complex was
extracted. The obtained ﬂuorescence spectra (dashed line) were
compared well with the measured spectra (solid line). It should
be emphasized that the ﬂuorescence spectra for the Al(III)–
Ab40 complex (dashed line of Al(III)–Ab40, Fig. 1D) and
the concentration proﬁles of the Al(III)–Ab40 complex in the
kinetic binding procedure, were obtained with the use of
MCR-ALS method. Such spectra are quite difﬁcult to obtaineta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
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These spectra indicated that Ab40 is able to form binary
complexes with Al(III).
3.2. Effect of Al(III) on Ab40 aggregation
The effect of Al(III) on Ab40 aggregation was ﬁrst assessed
with the use of UV–vis absorption (see Section 2.3.3); this
method is for exploring structural changes in biopolymers
and for conﬁrming any formation of ligand–protein complexes
(Bi et al., 2005; Kandagal et al., 2006). The Ab40 peptides
show a characteristic absorption peak at 285 nm, and conse-
quently when an Al(III) containing solution was added to
the sample, the peak intensity decreased at 285 nm
(Fig. 2A). This result indicated that in this context, Al(III)
may cause some changes to the peptide’s structure and content
in Ab40. In relation to these changes, an important issue to
investigate is whether or not the addition of Al(III) is associ-
ated with the formation of Ab40 aggregates such as b- or
amorphous types (Ha et al., 2007). In this context, any turbid-
ity of the sample indicates a change in optical density of the
analyte solution. Consequently, turbidity measurements canFigure 2 (A) UV–vis absorbance spectra of Ab40
(4.98 · 105 mol L1) in the presence of various concentrations
of Al(III) (0–1.88 · 105 mol L1 at intervals of
3.13 · 106 mol L1). (B) Turbidity (A405) of fresh Ab40, Ab
aggregates, and Al(III) induced Ab aggregates (sample prepara-
tion see Section 2.1).
Please cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
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including b- and amorphous ones (Ha et al., 2007). In this
work, turbidity was estimated indirectly with the use of UV–
vis absorption spectroscopy at 405 nm (Fig. 2B). For a fresh
Ab40 solution, the turbidity was quite low (0.004). However,
when the Ab40 solution was allowed to stand for three days
at 37 C in the presence of Al(III), turbidity increased substan-
tially (0.031). This indicated that Al(III) can facilitate the
aggregation of Ab40 amyloids.
To assess the degree of aggregation, a well-known aggrega-
tion marker, thiazine dye (ThT), was utilized (see Section 2.3.2)
(Khurana et al., 2005). This dye speciﬁcally binds to the aggre-
gated b-sheet ﬁbrils common to amyloid structures, and this
binding should lead to a signiﬁcant enhancement in ﬂuores-
cence of ThT according to the amount of the amyloid peptides
present (Khurana et al., 2005). Thus, a fresh Ab40 solution
showed only a weak response to ThT, (Fig. 3; curve 1), which
indicated that Ab40 exists almost unchanged, and when the
Ab40 solution was allowed to stand at 37 C, it behaved sim-
ilarly, (Fig. 3; curve 2), which indicated that only a small num-
ber of b-aggregates formed by the self-assembly process of the
peptides. In contrast, when the Al(III) solution was added to
either of the two above cases, the ﬂuorescence at 480 nm
increased substantially, which indicated that Ab40 in the pres-
ence of Al(III), was transformed from its initial state to the b-
structure (Fig. 3; curve 3). Furthermore, when Al(III) at a
higher concentration was added to the above two solutions,
ﬂuorescence intensity increased even more (Fig. 3; curve 4).
Thus, combining the above observations from the two experi-
ments, it is clear that Al(III) facilitates the aggregation of the
Ab40 peptides.
Circular dichroism (CD) spectroscopy provides general
indication for the increase in the b-structure content that
accompanies the aggregation of the Ab peptide. To investigate
the structural changes of the peptide, CD spectroscopy in the
far UV region (190–240 nm) was applied to detect any changes
in the secondary structure of Ab40 alone or in the presence of
0.56 mM and 1.12 mM of Al(III) solutions, respectively. To
provide further information on the aggregation of Ab40
induced by Al(III), the changes to the secondary structure of
Ab40 were investigated with the use of CD spectroscopy (see
Section 2.3.4 and Fig. 4). It is well known that theFigure 3 ThT ﬂuorescence spectra of fresh Ab40 and the Ab40
solution in the absence and presence of Al(III) after the reaction
period (samples prepared as in Section 2.1).
eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
Figure 4 CD spectra of Ab40 and the Ab40 solution in the
absence and presence of Al(III) after incubation (samples prepared
as in Section 2.1).
6 Q. Zhang et al.characteristic spectral peak for the b-sheet structure appears at
about 222 nm at which point, it has minimum ellipticity (Dai
et al., 2015; Petrlova et al., 2012). The untreated Ab40 amyloid
sample produced a typical CD spectrum of the random coil
conformation (curves 1 and 2) (Tickler et al., 2005), while, in
the case of the Ab40 sample solution, which was treated withFigure 5 AFM images of fresh Ab40: (A) Ab aggregates, (B) and Al(
sample D is higher than in C (prepared as in Section 2.1), and scan a
Please cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.019Al(III), the ellipticity of the random coil conformation was
found to be less negative (curves 3 and 4), and a characteristic
spectrum of the b-sheet structure appeared in the last spectrum
(see arrow).
These observations suggest that the presence of Al(III)
facilitates the transformation of the Ab40 peptides from the
initial random coil structure to the b-sheet protein. The conclu-
sion obtained here is consistent with the above observations
based on monitoring the ThT ﬂuorescence.
In addition, the size variations associated with the above
molecular interactions, and the surface morphology of the
untreated Ab40, Ab40 aggregates, and the Al(III) induced
Ab40 aggregate samples were analyzed with the use of a tap-
ping mode atomic force microscopy (AFM) (see
Section 2.3.5). The topography image for the Ab40 molecules
adsorbed on mica showed that this substance formed many
tiny particles on the surface (Fig. 5A). After treatment at
37 C for 3 days, much larger particles, which are much fewer
in number than in the ﬁrst case, were observed; on close exam-
ination, they appeared to have rough edges, which is a feature
that perhaps is indicative of such particles being formed by the
self-assembly process (Fig. 5B). When the Ab40 sample was
treated with Al(III) many, non-uniform, tightly packed ﬁbrils
were distributed on the mica surface in a disorderly manner
(Fig. 5C). These observations are consistent with those
reported for Zn and Cu in similar circumstances (ChenIII) induced Ab aggregates (C and D). Concentration of Al(III) in
rea is 2.0 lm · 2.0 lm.
eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
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tion, was used to treat an Ab40 sample, the morphology was
quite different – the Ab40 aggregate, was quite similar to that
observed in Fig. 5B, and appeared to pack into relatively long,
rigid rods (Fig. 5D); although these rods are larger, they are
otherwise quite similar to the ﬁbrils referred to in Fig. 5C.
These observations suggest that Al(III) can induce the forma-
tion of Ab40 aggregates, and may act as a mediator in the for-
mation of ﬁbrillar amyloid plaques in AD; clearly, the
concentration of the Al(III) solution is an important aspect
to consider when assessing the effect of Al(III) on the Ab40
aggregation. This work suggests that amyloid aggregates will
form in the presence of a wide range of concentrations.
However, it would appear that the morphology of these aggre-
gates will differ widely as a function of Al(III) concentration.
These aggregates appear to range from tiny particles to rela-
tively large ones, and they self-assemble into shapes ranging
from short strings to relatively long and apparently rigid rods.
4. Conclusion
It has been demonstrated with the use of ﬂuorescence, UV–vis,
CD, and AFM techniques that Al(III) can play an important
role as a mediator in the formation of ﬁbrillar amyloid plaques
in Alzheimer’s disease. The above analytical methods provided
collectively the information, which enabled the establishment
of reactants and products as well as the physical parameters;
these characterized the reaction mechanisms and kinetic rates
as well as the associated equilibrium constants. Furthermore,
some quantitative and qualitative information, such as the
binding constant of the interaction between Al(III) and Ab40,
and the spectrum of the binding complex of Al(III)-Ab40
can be obtained with the use of the MCR-ALS chemometrics
method. An important aspect of this work was the concentration
of Al(III) because it was an important variable which affected
the Ab40 aggregation process.
Acknowledgment
The authors gratefully acknowledge the ﬁnancial support of
this study by the National Natural Science Foundation
of China (NSFC-21065007), and the State Key Laboratory
of Food Science and Technology of Nanchang University
(SKLF-ZZA-201302 and SKLF-ZZB-201303).
References
Asandei, A., Iftemi, S., Mereuta, L., Schiopu, I., Luchian, T., 2014.
Probing of various physiologically relevant metals: amyloid-b
peptide interactions with a lipid membrane-immobilized protein
nanopore. J. Membr. Biol. 247, 523–530.
Bi, S.Y., Song, D.Q., Tian, Y., Zhou, X., Liu, Z.Y., Zhang, H.Q.,
2005. Molecular spectroscopic study on the interaction of tetracy-
clines with serum albumins. Spectrochim. Acta A 61, 629–636.
Bush, A.I., 2003. The metallobiology of Alzheimer’s disease. Trends
Neurosci. 26, 207–214.
Chen, T.T., Wang, X.Y., He, Y.F., Zhang, C.L., Wu, Z.Y., Liao, K.,
Wang, J.J., Guo, Z.J., 2009. Effects of cyclen and cyclam on zinc
(II)- and copper (II)-induced amyloid b-peptide aggregation and
neurotoxicity. Inorg. Chem. 48, 5801–5809.
Chiti, F., Dobson, C.M., 2006. Protein misfolding, functional amyloid,
and human disease. Annu. Rev. Biochem. 75, 333–366.Please cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.019Dai, X.L., Hou, W.Q., Sun, Y.X., Gao, Z.L., Zhu, S.G., Jiang, Z.F.,
2015. Chitosan oligosaccharides inhibit/disaggregate ﬁbrils and
attenuate amyloid b-mediated neurotoxicity. Int. J. Mol. Sci. 16,
10526–10536.
Drew, S.C., Barnham, K.J., 2010. The heterogeneous nature of Cu2+
interactions with Alzheimer’s amyloid-beta peptide. Acc. Chem.
Res. 44, 1146–1155.
Duce, J.A., Bush, A.L., 2010. Biological metals and Alzheimer’s
disease: implications for therapeutics and diagnostics. Prog.
Neurobiol. 92, 1–18.
Edelhoch, H., 1967. Spectroscopic determination of tryptophan and
tyrosine in proteins. Biochemistry 6, 1948–1954.
Gampp, H., Maeder, M., Meyer, C.J., Zuberbuhler, A.D., 1986.
Calculation of equilibrium constants from multiwavelength spec-
troscopic data-IV: model-free leaser-squares reﬁnement by use of
evolving factor analysis. Talanta 33, 943–951.
Ha, C., Ryu, J., Park, C.B., 2007. Metal ions differentially inﬂuence
the aggregation and deposition of Alzheimer’s b-amyloid on a solid
template. Biochemistry 46, 6118–6125.
Kandagal, P.B., Ashoka, S., Seetharamappa, J., Vani, V., Shaikh,
S.M.T., 2006. Study of the interaction between doxepin and human
serum albumin by spectroscopic methods. J. Photochem.
Photobiol. A 179, 161–166.
Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S.A., Krishna,
V., Grover, R.K., Roy, R., Singh, S., 2005. Mechanism of
thioﬂavin T binding to amyloid ﬁbrils. J. Struct. Biol. 151, 229–238.
Klatzo, I., Wisniewski, H., Streicher, E., 1965. Experimental
production of neuroﬁbrillary degeneration: 1. Light microscopic
observations. J. Neuropathol. Exp. Neurol. 24, 187–199.
Kumar, V., Gill, K.D., 2009. Aluminum neurotoxicity: neurobe-
havioural and oxidative aspects. Arch. Toxicol. 83, 965–978.
Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G.,
Yang, A., Gallagher, M., Ashe, K.H., 2005. A speciﬁc
amyloid-b protein assembly in the brain impairs memory.
Nature 440, 352–357.
Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L.,
Markesbery, W.R., 1998. Copper, iron and zinc in Alzheimer’s
disease senile plaques. J. Neurol. Sci. 158, 47–52.
Mattson, M.P., 2004. Pathways towards and away from Alzheimer’s
disease. Nature 430, 631–639.
Migliore, L., Coppede, F., 2009. Genetics, environmental factors and
the emerging role of epigenetics in neurodegenerative diseases.
Mutat. Res. 667, 82–97.
Miller, L.M., Wang, Q., Telivala, T.P., Smith, R.J., Lanzirotti, A.,
Miklossy, J., 2006. Synchrotron-based infrared and X-ray imaging
shows focalized accumulation of Cu and Zn co-localized with
b-amyloid deposits in Alzheimer’s disease. J. Struct. Biol. 155,
30–37.
Molina, H.F., Hider, R.C., Gaeta, A., Williams, R., Francis, P., 2007.
Metals ions and neurodegeneration. Biometals 20, 639–654.
Munoz, D.G., 1998. Is exposure of aluminum a risk factor for the
development of Alzheimer’s disease? Arch. Neurol. 55, 737–739.
Petrlova, J., Kalai, T., Maezawa, I., Altman, R., Harishchandra, G.,
Hong, H.S., Bricarello, D.A., Parikh, A.N., Lorigan, G.A., Jin,
L.W., 2012. The inﬂuence of spin-labeled ﬂuorene compounds on the
assembly and toxicity of the A beta peptide. PLoS One 7, e35443.
Rauk, A., 2009. The chemistry of Alzheimer’s disease. Chem. Soc.
Rev. 38, 2698–2715.
Ricchelli, F., Buggio, R., Drago, D., Salmona, M., Forloni, G., Negro,
A., Tognon, G., Zatta, P., 2006. Aggregation/ﬁbrillogenesis of
recombinant human prion protein and Gerstmann–Stra¨ussler–
Scheinker disease peptides in the presence of metal ions.
Biochemistry 45, 6724–6732.
Rozga, M., Kloniecki, M., Dadle, M., Bal, W., 2010. A direct
determination of the dissociation constant for the Cu(II)
complex of amyloid b 1–40 peptide. Chem. Res. Toxicol. 23,
336–340.eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
8 Q. Zhang et al.Storr, T., Merkel, M., Song-Zhao, G.X., Scott, L.E., Green, D.E.,
Bowen, M.L., Thompson, K.H., Patrick, B.O., Schugar, H.J.,
Orvig, C., 2007. Synthesis, characterization, and metal coordinat-
ing ability of multifunctional carbohydrate-containing compounds
for Alzheimer’s therapy. J. Am. Chem. Soc. 129, 7453–7463.
Tauler, R., 1995. Multivariate curve resolution applied to second order
data. Chemom. Intell. Lab. Syst. 30, 133–146.
Terry, R.D., Pena, C., 1965. Experimental production of neuroﬁbrillary
degeneration: 2. Electron microscopy, phosphatase histochemistry
and electronprose analysis. J.Neuropathol. Exp.Neurol. 24, 200–210.
Tickler, A.K., Smith, D.G., Ciccotosto, G.D., Tew, D.J., Curtain,
C.C., Carrington, D., Masters, C.L., Bush, A.I., Cherny, R.A.,
Cappai, R., Wade, J.D., Barnham, K.J., 2005. Methylation of the
imidazole side chains of the Alzheimer disease amyloid-beta
peptide results in abolition of superoxide dismutase-like structures
and inhibition of neurotoxicity. J. Biol. Chem. 280, 13355–13363.Please cite this article in press as: Zhang, Q. et al., Eﬀects of aluminum on amyloid-b
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.019Walton, J.R., 2006. Aluminum in hippocampal neurons from humans
with Alzheimer’s disease. Neurotoxicology 27, 385–394.
Warmlander, S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J.,
Soderberg, K.L., Danielsson, J., Garslund, A., 2013. Biophysical
studies of the amyloid b-peptide: interactions with metal ions and
small molecules. ChemBioChem 14, 1692–1704.
Vives, M., Gragallo, R., Tauler, R., 2000. Multivariate extension of
the continuous variation and mole-ratio methods for the study of
the interaction of intercalators with polynucleotides. Anal. Chim.
Acta 424, 105–114.
Zatta, P., 1993. Controversial aspects of aluminium(III) accumulation
and subcompartmentation in Alzheimer’s disease. Trace. Elem.
Med. 10, 120–128.
Zatta, P., Lucchini, R., Van Rensburg, S.J., Taylor, A., 2003. The role
of metals in neurodegenerative processes: aluminum, manganese
and zinc. Brain Res. Bull. 62, 15–28.eta aggregation in the context of Alzheimer’s disease. Arabian Journal of Chem-
